BG Medicine, Inc.
BGMD
$0.00
$0.000.00%
| 12/31/2015 | 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | |
|---|---|---|---|---|---|
| Net Income | -902.00K | -1.02M | -2.03M | -1.35M | -1.32M |
| Total Depreciation and Amortization | 18.00K | 17.00K | 23.00K | 29.00K | 31.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 162.00K | 233.00K | 921.00K | 257.00K | 240.00K |
| Change in Net Operating Assets | -395.00K | 441.00K | 259.00K | -329.00K | -21.00K |
| Cash from Operations | -1.12M | -332.00K | -827.00K | -1.39M | -1.07M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 13.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | 13.00K | -- | -- |
| Total Debt Issued | 0.00 | 0.00 | 500.00K | -- | -- |
| Total Debt Repaid | 0.00 | -744.00K | -1.12M | -1.12M | -1.12M |
| Issuance of Common Stock | 0.00 | 2.50M | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 2.00M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -960.00K | -- | -- | 0.00 |
| Cash from Financing | 0.00 | 2.80M | -620.00K | -1.12M | -1.12M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.12M | 2.46M | -1.43M | -2.51M | -2.19M |
